Beihai Gofar Marine Biological Industry Co Ltd (600538) - Total Liabilities
Based on the latest financial reports, Beihai Gofar Marine Biological Industry Co Ltd (600538) has total liabilities worth CN¥179.09 Million CNY (≈ $26.21 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Beihai Gofar Marine Biological Industry (600538) cash conversion ratio to assess how effectively this company generates cash.
Beihai Gofar Marine Biological Industry Co Ltd - Total Liabilities Trend (1999–2024)
This chart illustrates how Beihai Gofar Marine Biological Industry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Beihai Gofar Marine Biological Industry (600538) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Beihai Gofar Marine Biological Industry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beihai Gofar Marine Biological Industry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Anglo American PLC
LSE:AAL
|
UK | GBX31.89 Billion |
|
Shelf Drilling Ltd
OL:SHLF
|
Norway | Nkr1.56 Billion |
|
Issta Lines Ltd
TA:ISTA
|
Israel | ILA2.29 Billion |
|
Clenergy Xiamen Technology Co Ltd
SHG:603628
|
China | CN¥2.22 Billion |
|
Nanjing TDH Technology Co. Ltd. A
SHE:301378
|
China | CN¥264.18 Million |
|
SunOpta Inc.
NASDAQ:STKL
|
USA | $516.07 Million |
|
Ichitan Group Public Company Limited
BK:ICHI-R
|
Thailand | ฿1.40 Billion |
|
Kaiser China Holding Co Ltd
SHE:002425
|
China | CN¥363.54 Million |
Liability Composition Analysis (1999–2024)
This chart breaks down Beihai Gofar Marine Biological Industry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 600538 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.19 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beihai Gofar Marine Biological Industry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beihai Gofar Marine Biological Industry Co Ltd (1999–2024)
The table below shows the annual total liabilities of Beihai Gofar Marine Biological Industry Co Ltd from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥179.36 Million ≈ $26.25 Million |
+1.78% |
| 2023-12-31 | CN¥176.22 Million ≈ $25.79 Million |
-3.27% |
| 2022-12-31 | CN¥182.17 Million ≈ $26.66 Million |
+13.74% |
| 2021-12-31 | CN¥160.16 Million ≈ $23.44 Million |
-25.21% |
| 2020-12-31 | CN¥214.15 Million ≈ $31.34 Million |
+105.05% |
| 2019-12-31 | CN¥104.44 Million ≈ $15.28 Million |
-16.99% |
| 2018-12-31 | CN¥125.82 Million ≈ $18.41 Million |
+7.01% |
| 2017-12-31 | CN¥117.57 Million ≈ $17.20 Million |
-56.28% |
| 2016-12-31 | CN¥268.93 Million ≈ $39.35 Million |
+9.24% |
| 2015-12-31 | CN¥246.18 Million ≈ $36.02 Million |
-5.88% |
| 2014-12-31 | CN¥261.57 Million ≈ $38.28 Million |
-54.84% |
| 2013-12-31 | CN¥579.21 Million ≈ $84.76 Million |
+10.88% |
| 2012-12-31 | CN¥522.38 Million ≈ $76.44 Million |
+3.46% |
| 2011-12-31 | CN¥504.93 Million ≈ $73.89 Million |
+4.91% |
| 2010-12-31 | CN¥481.29 Million ≈ $70.43 Million |
-34.61% |
| 2009-12-31 | CN¥736.06 Million ≈ $107.71 Million |
-16.53% |
| 2008-12-31 | CN¥881.78 Million ≈ $129.03 Million |
+8.15% |
| 2007-12-31 | CN¥815.31 Million ≈ $119.30 Million |
+5.65% |
| 2006-12-31 | CN¥771.73 Million ≈ $112.93 Million |
+7.73% |
| 2005-12-31 | CN¥716.35 Million ≈ $104.82 Million |
+36.96% |
| 2004-12-31 | CN¥523.05 Million ≈ $76.54 Million |
+100.14% |
| 2003-12-31 | CN¥261.34 Million ≈ $38.24 Million |
+198.04% |
| 2002-12-31 | CN¥87.69 Million ≈ $12.83 Million |
+14.61% |
| 2001-12-31 | CN¥76.51 Million ≈ $11.20 Million |
-15.46% |
| 2000-12-31 | CN¥90.50 Million ≈ $13.24 Million |
+33.42% |
| 1999-12-31 | CN¥67.83 Million ≈ $9.93 Million |
-- |
About Beihai Gofar Marine Biological Industry Co Ltd
Beihai Gofar Chuanshan Biological Co., Ltd., together with its subsidiaries, engages in the distribution of pharmaceutical products in China. It operates through Pharmaceutical Distribution [Industry]; Pharmaceutical Manufacturing; DNA Testing Equipment, Consumables and Testing Services; and Others segments. The company wholesales and retails various medicines and medical devices through directly… Read more